Proteomic study of acute respiratory distress syndrome: current knowledge and implications for drug development

References

• Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):818–824.
   PubMed Web of Science ®Google Scholar
• Ferguson ND, Fan E, Camporota L, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012 Oct;38(10):1573–1582.
   PubMed Web of Science ®Google Scholar
• Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1334–1349.
   PubMed Web of Science ®Google Scholar
• Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005 Oct 20;353(16):1685–1693.
   PubMed Web of Science ®Google Scholar
• Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest. 2012 Aug 1;122(8):2731–2740.
   PubMed Web of Science ®Google Scholar
• Villar J, Sulemanji D, Kacmarek RM. The acute respiratory distress syndrome: incidence and mortality, has it changed? Curr Opin Crit Care. 2014 Feb;20(1):3–9.
   PubMed Web of Science ®Google Scholar
• Papazian L, Forel J-M, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010 Sep 16;363(12):1107–1116.
   PubMed Web of Science ®Google Scholar
• Stapleton RD, Wang BM, Hudson LD, et al. Causes and timing of death in patients with ARDS. Chest. 2005 Aug;128(2):525–532.
   PubMed Web of Science ®Google Scholar
• Villar J, Pérez-Méndez L, Blanco J, et al. A universal definition of ARDS: the PaO2/FiO2 ratio under a standard ventilatory setting–a prospective, multicenter validation study. Intensive Care Med. 2013 Apr;39(4):583–592.
   PubMed Web of Science ®Google Scholar
• Guérin C, Reignier J, Richard J-C. Prone positioning in the acute respiratory distress syndrome. N Engl J Med. 2013 Sep 5;369(10):980–981.
   PubMed Web of Science ®Google Scholar
• Olman MA, White KE, Ware LB, et al. Pulmonary edema fluid from patients with early lung injury stimulates fibroblast proliferation through IL-1 beta-induced IL-6 expression. J Immunol. 2004 Feb 15;172(4):2668–2677.
   PubMed Web of Science ®Google Scholar
• Kurova VS, Anaev EC, Kononikhin AS, et al. Proteomics of exhaled breath: methodological nuances and pitfalls. Clin Chem Lab Med. 2009;47(6):706–712.
   PubMed Web of Science ®Google Scholar
• Levitt JE, Gould MK, Ware LB, et al. The pathogenetic and prognostic value of biologic markers in acute lung injury. J Intensive Care Med. 2009 May–Jun;24(3):151–167.
   PubMedGoogle Scholar
• Pittet JF, Mackersie RC, Martin TR, et al. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med. 1997 Apr;155(4):1187–1205.
   PubMed Web of Science ®Google Scholar
• Terpstra ML, Aman J, van Nieuw Amerongen GP, et al. Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis*. Crit Care Med. 2014 Mar;42(3):691–700.
   PubMed Web of Science ®Google Scholar
• Walter JM, Wilson J, Ware LB. Biomarkers in acute respiratory distress syndrome: from pathobiology to improving patient care. Expert Rev Respir Med. 2014 Oct;8(5):573–586.
   PubMed Web of Science ®Google Scholar
• Rubin DB, Wiener-Kronish JP, Murray JF, et al. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest. 1990 Aug;86(2):474–480.
   PubMed Web of Science ®Google Scholar
• Moss M, Ackerson L, Gillespie MK, et al. von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome. Am J Respir Crit Care Med. 1995 Jan;151(1):15–20.
   PubMed Web of Science ®Google Scholar
• Bajaj MS, Tricomi SM. Plasma levels of the three endothelial-specific proteins von Willebrand factor, tissue factor pathway inhibitor, and thrombomodulin do not predict the development of acute respiratory distress syndrome. Intensive Care Med. 1999 Nov;25(11):1259–1266.
   PubMed Web of Science ®Google Scholar
• Ware LB, Eisner MD, Thompson BT, et al. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med. 2004 Oct 1;170(7):766–772.
   PubMed Web of Science ®Google Scholar
• Calfee CS, Gallagher D, Abbott J, et al. Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance. Crit Care Med. 2012 Jun;40(6):1731–1737.
   PubMed Web of Science ®Google Scholar
• Ware LB, Conner ER, Matthay MA. von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med. 2001 Dec;29(12):2325–2331.
   PubMed Web of Science ®Google Scholar
• Parikh SM, Mammoto T, Schultz A, et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 2006 Mar;3(3):e46.
   PubMed Web of Science ®Google Scholar
• Bhandari V, Choo-Wing R, Lee CG, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med. 2006 Nov;12(11):1286–1293.
   PubMed Web of Science ®Google Scholar
• Gallagher DC, Parikh SM, Balonov K, et al. Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock. 2008 Jun;29(6):656–661.
   PubMed Web of Science ®Google Scholar
• van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, et al. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax. 2008 Jun 17;63:903–909.
   PubMed Web of Science ®Google Scholar
• Conner ER, Ware LB, Modin G, et al. Elevated pulmonary edema fluid concentrations of soluble intercellular adhesion molecule-1 in patients with acute lung injury: biological and clinical significance. Chest. 1999 Jul;116(1 Suppl):83S–84S.
   PubMed Web of Science ®Google Scholar
• Agouridakis P, Kyriakou D, Alexandrakis MG, et al. The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res. 2002;3:25.
   PubMed Web of Science ®Google Scholar
• Flori HR, Ware LB, Glidden D, et al. Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation. Pediatr Crit Care Med. 2003 Jul;4(3):315–321.
   PubMedGoogle Scholar
• McClintock D, Zhuo H, Wickersham N, et al. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care. 2008;12(2):R41.
   PubMed Web of Science ®Google Scholar
• Calfee CS, Ware LB, Eisner MD, et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax. 2008 Dec;63(12):1083–1089.
   Google Scholar
• Ribes JA, Francis CW, Wagner DD. Fibrin induces release of von Willebrand factor from endothelial cells. J Clin Invest. 1987 Jan;79(1):117–123.
   PubMed Web of Science ®Google Scholar
• Okajima K, Harada N, Sakurai G, et al. Rapid assay for plasma soluble E-selectin predicts the development of acute respiratory distress syndrome in patients with systemic inflammatory response syndrome. Transl Res. 2006 Dec;148(6):295–300.
   PubMed Web of Science ®Google Scholar
• Donnelly SC, Haslett C, Dransfield I, et al. Role of selectins in development of adult respiratory distress syndrome. Lancet. 1994 Jul 23;344(8917):215–219.
   PubMed Web of Science ®Google Scholar
• Abadie Y, Bregeon F, Papazian L, et al. Decreased VEGF concentration in lung tissue and vascular injury during ARDS. Eur Respir J. 2005 Jan;25(1):139–146.
   PubMed Web of Science ®Google Scholar
• Maitre B, Boussat S, Jean D, et al. Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J. 2001 Jul;18(1):100–106.
   PubMed Web of Science ®Google Scholar
• Thickett DR, Armstrong L, Christie SJ, et al. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001 Nov 1;164(9):1601–1605.
   PubMed Web of Science ®Google Scholar
• Thickett DR, Armstrong L, Millar AB. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med. 2002 Nov 15;166(10):1332–1337.
   PubMed Web of Science ®Google Scholar
• Ware LB, Kaner RJ, Crystal RG, et al. VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema. Eur Respir J. 2005 Jul;26(1):101–105.
   PubMed Web of Science ®Google Scholar
• Cheng IW, Ware LB, Greene KE, et al. Prognostic value of surfactant proteins A and D in patients with acute lung injury. Crit Care Med. 2003 Jan;31(1):20–27.
   PubMed Web of Science ®Google Scholar
• Greene KE, Wright JR, Steinberg KP, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med. 1999 Dec;160(6):1843–1850.
   PubMed Web of Science ®Google Scholar
• Eisner MD, Parsons P, Matthay MA, et al. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax. 2003 Nov;58(11):983–988.
   PubMed Web of Science ®Google Scholar
• Ware LB, Koyama T, Zhao Z, et al. Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care. 2013;17(5):R253.
   PubMed Web of Science ®Google Scholar
• Calfee CS, Budev MM, Matthay MA, et al. Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. J Heart Lung Transplant. 2007 Jul;26(7):675–680.
   PubMed Web of Science ®Google Scholar
• Uchida T, Shirasawa M, Ware LB, et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med. 2006 May 1;173(9):1008–1015.
   PubMed Web of Science ®Google Scholar
• Ishizaka A, Matsuda T, Albertine KH, et al. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2004 Jun;286(6):L1088–L1094.
   PubMed Web of Science ®Google Scholar
• The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301–1308.
   Google Scholar
• Agrawal A, Zhuo H, Brady S, et al. Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials. Am J Physiol Lung Cell Mol Physiol. 2012 Oct 15;303(8):L634–L639.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Headley S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest. 1995 Apr;107(4):1062–1073.
   PubMed Web of Science ®Google Scholar
• Calfee CS, Eisner MD, Ware LB, et al. Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med. 2007 Jul 17;35:2243–2250.
   PubMed Web of Science ®Google Scholar
• Parsons PE, Matthay MA, Ware LB, et al. Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2005 Mar;288(3):L426–L431.
   PubMed Web of Science ®Google Scholar
• Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005 Jan;33(1):1–6; discussion 230–232.
   PubMed Web of Science ®Google Scholar
• Pugin J, Ricou B, Steinberg KP, et al. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1850–1856.
   PubMed Web of Science ®Google Scholar
• Miller EJ, Cohen AB, Nagao S, et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis. 1992 Aug;146(2):427–432.
   PubMed Web of Science ®Google Scholar
• Fowler AA, Hyers TM, Fisher BJ, et al. The adult respiratory distress syndrome. Cell populations and soluble mediators in the air spaces of patients at high risk. Am Rev Respir Dis. 1987 Nov;136(5):1225–1231.
   PubMed Web of Science ®Google Scholar
• Weiland JE, Davis WB, Holter JF, et al. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am Rev Respir Dis. 1986 Feb;133(2):218–225.
   PubMed Web of Science ®Google Scholar
• Pugin J, Verghese G, Widmer MC, et al. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med. 1999 Feb;27(2):304–312.
   PubMed Web of Science ®Google Scholar
• Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis. 1990 Feb;141(2):471–501.
   PubMed Web of Science ®Google Scholar
• Matute-Bello G, Liles WC, Radella F 2nd, et al. Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Crit Care Med. 2000 Jan;28(1):1–7.
   PubMed Web of Science ®Google Scholar
• Ware LB, Fang X, Matthay MA. Protein C and thrombomodulin in human acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2003 Sep;285(3):L514–L521.
   PubMed Web of Science ®Google Scholar
• Prabhakaran P, Ware LB, White KE, et al. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L20–L28.
   PubMed Web of Science ®Google Scholar
• Jalkanen V, Yang R, Linko R, et al. SuPAR and PAI-1 in critically ill, mechanically ventilated patients. Intensive Care Med. 2013 Mar;39(3):489–496.
   PubMed Web of Science ®Google Scholar
• Zhu S, Ware LB, Geiser T, et al. Increased levels of nitrate and surfactant protein a nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med. 2001 Jan;163(1):166–172.
   PubMed Web of Science ®Google Scholar
• Sharkey RA, Donnelly SC, Connelly KG, et al. Initial serum ferritin levels in patients with multiple trauma and the subsequent development of acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1506–1509.
   PubMed Web of Science ®Google Scholar
• Connelly KG, Moss M, Parsons PE, et al. Serum ferritin as a predictor of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997 Jan;155(1):21–25.
   PubMed Web of Science ®Google Scholar
• Bowler RP, Velsor LW, Duda B, et al. Pulmonary edema fluid antioxidants are depressed in acute lung injury. Crit Care Med. 2003 Sep;31(9):2309–2315.
   PubMed Web of Science ®Google Scholar
• Martin C, Papazian L, Payan MJ, et al. Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. Chest. 1995 Jan;107(1):196–200.
   PubMed Web of Science ®Google Scholar
• Chesnutt AN, Matthay MA, Tibayan FA, et al. Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):840–845.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Tolley EA, Chinn A, et al. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1432–1441.
   PubMed Web of Science ®Google Scholar
• Madtes DK, Rubenfeld G, Klima LD, et al. Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1998 Aug;158(2):424–430.
   PubMed Web of Science ®Google Scholar
• Chesnutt AN, Kheradmand F, Folkesson HG, et al. Soluble transforming growth factor-alpha is present in the pulmonary edema fluid of patients with acute lung injury. Chest. 1997 Mar;111(3):652–656.
   PubMed Web of Science ®Google Scholar
• Matute-Bello G, Liles WC, Steinberg KP, et al. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol. 1999 Aug 15;163(4):2217–2225.
   PubMed Web of Science ®Google Scholar
• Albertine KH, Soulier MF, Wang Z, et al. Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol. 2002 Nov;161(5):1783–1796.
   PubMed Web of Science ®Google Scholar
• Hashimoto S, Kobayashi A, Kooguchi K, et al. Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med. 2000 Jan;161(1):237–243.
   PubMed Web of Science ®Google Scholar
• Tenholder MF, Rajagopal KR, Phillips YY, et al. Urinary desmosine excretion as a marker of lung injury in the adult respiratory distress syndrome. Chest. 1991 Nov;100(5):1385–1390.
   PubMed Web of Science ®Google Scholar
• Fill JA, Brandt JT, Wiedemann HP, et al. Urinary desmosine as a biomarker in acute lung injury. Biomarkers. 2006 Jan–Feb;11(1):85–96.
   PubMed Web of Science ®Google Scholar
• Fay PJ, Coumans JV, Walker FJ. von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. J Biol Chem. 1991 Feb 5;266(4):2172–2177.
   PubMed Web of Science ®Google Scholar
• Hamilton KK, Sims PJ. Changes in cytosolic Ca2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. Study of microcarrier cell monolayers using the fluorescent probe indo-1. J Clin Invest. 1987 Feb;79(2):600–608.
   PubMed Web of Science ®Google Scholar
• Collins PW, Macey MG, Cahill MR, et al. von Willebrand factor release and P-selectin expression is stimulated by thrombin and trypsin but not IL-1 in cultured human endothelial cells. Thromb Haemost. 1993 Aug 2;70(2):346–350.
   PubMed Web of Science ®Google Scholar
• Hordijk PL. Endothelial signalling events during leukocyte transmigration. The FEBS Journal. 2006 Oct;273(19):4408–4415.
   PubMed Web of Science ®Google Scholar
• Chroneos ZC, Sever-Chroneos Z, Shepherd VL. Pulmonary surfactant: an immunological perspective. Cell Physiol Biochem. 2010;25(1):13–26.
   PubMed Web of Science ®Google Scholar
• Pastva AM, Wright JR, Williams KL. Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc Am Thorac Soc. 2007 Jul;4(3):252–257.
   PubMedGoogle Scholar
• Liliensiek B, Weigand MA, Bierhaus A, et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest. 2004 Jun;113(11):1641–1650.
   PubMed Web of Science ®Google Scholar
• Xie J, Méndez JD, Méndez-Valenzuela V, et al. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signal. 2013 Nov;25(11):2185–2197.
   PubMed Web of Science ®Google Scholar
• Jabaudon M, Futier E, Roszyk L, et al. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med. 2011 Mar;39(3):480–488.
   PubMed Web of Science ®Google Scholar
• Calfee CS, Ware LB, Eisner MD, et al. Plasma receptor for advanced glycation end-products and clinical outcomes in acute lung injury. Thorax. 2008 Jun 19;63:1083–1089.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Matthay MA, Kangelaris KN, et al. Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients. Am J Respir Crit Care Med. 2013 Apr 1;187(7):736–742.
   PubMed Web of Science ®Google Scholar
• Hirasawa Y, Kohno N, Yokoyama A, et al. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol. 1997 Oct;17(4):501–507.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998 Jul 8;280(2):159–165.
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006 Apr 20;354(16):1671–1684. doi:10.1056/NEJMoa051693.
   PubMed Web of Science ®Google Scholar
• Rice TW, Wheeler AP, Morris PE, et al. Safety and efficacy of affinity-purified, anti-tumor necrosis factor-alpha, ovine fab for injection (CytoFab) in severe sepsis. Crit Care Med. 2006 Sep;34(9):2271–2281.
   PubMed Web of Science ®Google Scholar
• Bernard GR, Francois B, Mira J-P, et al. Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study*. Crit Care Med. 2014 Mar;42(3):504–511.
   PubMed Web of Science ®Google Scholar
• Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001 Mar 8;344(10):699–709.
   PubMed Web of Science ®Google Scholar
• Choi G, Schultz MJ, van Till JW, et al. Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur Respir J. 2004 Nov;24(5):786–789.
   PubMed Web of Science ®Google Scholar
• Günther A, Mosavi P, Heinemann S, et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):454–462.
   PubMed Web of Science ®Google Scholar
• Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med. 2003 Apr;31(4 Suppl):S213–S220.
   PubMed Web of Science ®Google Scholar
• Schultz MJ, Millo J, Levi M, et al. Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax. 2004 Feb;59(2):130–135.
   PubMed Web of Science ®Google Scholar
• Ware LB, Matthay MA, Parsons PE, et al. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med. 2007 Aug;35(8):1821–1828.
   PubMed Web of Science ®Google Scholar
• Liu KD, Levitt J, Zhuo H, et al. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med. 2008 Jun 19;178:618–623.
   PubMed Web of Science ®Google Scholar
• Galani V, Tatsaki E, Bai M, et al. The role of apoptosis in the pathophysiology of acute respiratory distress syndrome (ARDS): an up-to-date cell-specific review. Pathol Res Pract. 2010 Mar 15;206(3):145–150.
   PubMed Web of Science ®Google Scholar
• Verghese GM, McCormick-Shannon K, Mason RJ, et al. Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance. Am J Respir Crit Care Med. 1998 Aug;158(2):386–394.
   PubMed Web of Science ®Google Scholar
• Ware LB, Matthay MA. Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol. 2002 May;282(5):L924–L940.
   PubMed Web of Science ®Google Scholar
• Lee JW, Krasnodembskaya A, McKenna DH, et al. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med. 2013 Apr 1;187(7):751–760.
   PubMed Web of Science ®Google Scholar
• Atabai K, Ishigaki M, Geiser T, et al. Keratinocyte growth factor can enhance alveolar epithelial repair by nonmitogenic mechanisms. Am J Physiol Lung Cell Mol Physiol. 2002 Jul;283(1):L163–L169.
   PubMed Web of Science ®Google Scholar
• Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014 Aug;2(8):611–620.
   PubMed Web of Science ®Google Scholar
• Brower RG, Lanken PN, MacIntyre N, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004 Jul 22;351(4):327–336.
   PubMed Web of Science ®Google Scholar
• Calfee CS, Janz DR, Bernard GR, et al. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest. 2015 Jun;147(6):1539–1548.
   PubMed Web of Science ®Google Scholar
• O’Neal HR Jr, Koyama T, Koehler EAS, et al. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med. 2011 Jun;39(6):1343–1350.
   PubMed Web of Science ®Google Scholar
• Wiedemann HP, Wheeler AP, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006 Jun 15;354(24):2564–2575.
   PubMed Web of Science ®Google Scholar
• Fremont RD, Koyama T, Calfee CS, et al. Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis. J Trauma. 2010 May;68(5):1121–1127.
   PubMedGoogle Scholar
• Calfee CS, Ware LB, Glidden DV, et al. Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med. 2011 Apr;39(4):711–717.
   PubMed Web of Science ®Google Scholar
• Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003 Mar 13;422(6928):198–207.
   PubMed Web of Science ®Google Scholar
• Ong S-E, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol. 2005 Oct;1(5):252–262.
   PubMed Web of Science ®Google Scholar
• Chang DW, Hayashi S, Gharib SA, et al. Proteomic and computational analysis of bronchoalveolar proteins during the course of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2008 Oct 1;178(7):701–709.
   PubMed Web of Science ®Google Scholar
• Schnapp LM, Donohoe S, Chen J, et al. Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury. Am J Pathol. 2006 Jul;169(1):86–95.
   PubMed Web of Science ®Google Scholar
• Bowler RP, Duda B, Chan ED, et al. Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2004 Jun;286(6):L1095–L1104.
   PubMed Web of Science ®Google Scholar
• Bhargava M, Becker TL, Viken KJ, et al. Proteomic profiles in acute respiratory distress syndrome differentiates survivors from non-survivors. PLoS One. 2014;9(10):e109713.
   PubMed Web of Science ®Google Scholar
• De Torre C, Ying S-X, Munson PJ, et al. Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics. 2006 Jul;6(13):3949–3957.
   PubMed Web of Science ®Google Scholar
• Chen X, Shan Q, Jiang L, et al. Quantitative proteomic analysis by iTRAQ for identification of candidate biomarkers in plasma from acute respiratory distress syndrome patients. Biochem Biophys Res Commun. 2013 Nov 8;441(1):1–6.
   PubMed Web of Science ®Google Scholar
• Gessner C, Dihazi H, Brettschneider S, et al. Presence of cytokeratins in exhaled breath condensate of mechanical ventilated patients. Res Med. 2008;102(2):299–306.
   PubMed Web of Science ®Google Scholar
• Erickson SE, Martin GS, Davis JL, et al. Recent trends in acute lung injury mortality: 1996–2005. Crit Care Med. 2009 May;37(5):1574–1579.
   PubMed Web of Science ®Google Scholar